z Score |
Function |
Genes |
Stromal |
−2.190 |
Immune cell trafficking decrease |
MYD88 upstream |
−2.366 |
Antigen-presenting cell movement decrease |
C3, CXCL12, IL15, MYD88, PLXND1, PTGDS, SELE |
−2.000 |
Mast cell migration decrease |
C3, CXCL12, IL15, PIK3R1 |
−2.216 |
Macrophage cell movement decrease |
C3, CXCL12, IL15, PLXND1, PTGDS |
−2.177 |
Phagocyte maturation decrease |
CSF3, IL-15, MYD88, PIK3R1, SERPINA1 |
−2.219 |
Inflammatory disease decrease |
C3, CXCL12, DLL4, MYD88, PIK3R1 |
2.321 |
Cell morphology increases cell size |
CBS, DEPTOR, PIM2, PLCB1, UCN2, IGFBP2 |
2.186 |
Muscle cell migration increase |
IGFBP2, MMP7, MYOCD, POSTN, SERPINA1 |
Epithelial |
2.268 |
Cancer increase |
TGFβ1 upstream |
2.537 |
Tumor cell proliferation increase |
AXL, CST6, IL1RN, MMP2, NOS2, PTGS2 (COX2), ZEB1 |
2.420 |
Vascularization increase |
ADAMTS1, ALOX5, FGF2, IGF2, IL1B, NOS2, NRP2, SPARC |
2.803 |
Cell migration increase |
ALOX5, AXL, CDK6, CHST10, CXCL5, FGF2, FMOD, GCNT1, HEY1, IGF2,
IL1B, NOS2, NQO1, NRP2, RAP1GAP, SPARC, SPDEF, TGM2 |
2.608 |
Leukocyte migration increase |
ALOX5, AQP9, CXCL5, FGF2, GCNT1, IGF2, IL1B, NOS2, NQO1, NRP2,
RAP1GAP, SPARC, SPDEF, TGM2 |
DAVID |
Function |
Gene Number |
Enrichment |
P Value |
Benjamini |
Stromal |
150 genes |
|
|
|
Signal |
64 |
8.34 |
2.3 × 10−13
|
5.9 × 10−11
|
Extracellular region |
29 |
5.03 |
4.9 × 10−8
|
4.6 × 10−6
|
Cell adhesion |
17 |
3.54 |
4.5 × 10−4
|
7.4 × 10−2
|
Vasculature development |
12 |
2.66 |
1.4 × 10−5
|
4.2 × 10−3
|
EGF-like region |
10 |
2.17 |
7.5 × 10−4
|
1.5 × 10−1
|
Neuropeptide signal |
7 |
1.88 |
1.7 × 10−4
|
4.1 × 10−2
|
Carbohydrate binding |
11 |
1.83 |
7.2 × 10−4
|
1.2 × 10−1
|
Hormone regulation |
8 |
1.78 |
3.9 × 10−4
|
7.4 × 10−2
|
Epithelial |
213 genes |
|
|
|
Extracellular |
35 |
5.41 |
8.1 × 10−8
|
1.9 × 10−5
|
Signal |
48 |
5.37 |
1.6 × 10−9
|
5.6 × 10−7
|
Vasculature development |
11 |
2.44 |
1.1 × 10−3
|
1.3 × 10−1
|
Oxidoreductase |
19 |
2.27 |
4.7 × 10−5
|
3.3 × 10−3
|